You must be 21+ years old to visit our website. Select your preference below.
Important Disclaimer: This product is sold strictly for research and laboratory use only and is not intended for human or animal consumption, medical, diagnostic, or therapeutic purposes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
$79.99
Currently unavailable
CJC-1295 with DAC is a long-acting GHRH analog commonly studied in research involving:
CJC-1295 with DAC is a modified 29-amino-acid GHRH analog engineered with a Drug Affinity Complex. The reactive DAC group binds covalently to circulating albumin, greatly extending exposure compared with unmodified GHRH(1–29) and short-acting “No DAC” research materials.
Published laboratory, animal, and early human research has examined its effects on pituitary growth hormone release, preservation of pulsatile secretion, mean growth hormone concentration, and downstream IGF-1 levels. Its extended activity results from albumin binding rather than from the peptide becoming growth hormone itself.
The published CJC-1295 literature applies to a specifically characterized DAC-modified molecule. It should not be transferred to “CJC-1295 No DAC” products or to material whose sequence and reactive modification have not been analytically confirmed. This research material is not an FDA-approved clinical product.
IMPORTANT DISCLAIMER — FOR LABORATORY RESEARCH USE ONLY
This product is intended exclusively for laboratory research purposes. It is not intended for human or animal consumption or for human or veterinary use, administration, ingestion, injection, inhalation, implantation, topical application, compounding, medical use, diagnostic use, or therapeutic use.
This product is not approved by the U.S. Food and Drug Administration for human or veterinary use. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. AF Peptides makes no representation regarding its safety, effectiveness, or suitability for any clinical, therapeutic, diagnostic, personal, or household application.
